In patients with alcoholic hepatitis, assessment of mortality risk is a key factor in the clinical management. Within the last decade, several prognostic scores have emerged. We aimed to evaluate and compare the predictive performances of the Glasgow alcoholic hepatitis score (GAHS); the model of end-stage liver disease (MELD); the MELD-Na; the Lille model; and the age, bilirubin, international normalized ratio, and creatinine (ABIC) score in a population-based unselected cohort of patients with alcoholic hepatitis.